No Data
No Data
No Data
No Data
No Data
Press Release: TFF Pharmaceuticals Announces Closing of Pricing of $4.8 Million Public Offering
TFF Pharmaceuticals Announces Closing of Pricing of $4.8 Million Public Offering FORT WORTH, Texas, May 01, 2024 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc (Nasdaq: TFFP) (the "Company" or "TFF Pha
Dow JonesMay 2 05:07
TFF Pharmaceuticals Prices $4.8 Million Public Offering; Shares Down Pre-Bell
TFF Pharmaceuticals (TFFP) said late Monday it priced a public offering of about 1.7 million common shares and warrants to purchase up to about 1.7 million shares at a combined price of $2.875 per sha
MT NewswiresApr 30 17:53
Reported Earlier, TFF Pharmaceuticals Prices $4.8M Public Offering Of 1,665,219 Shares And Warrants At $2.875/Share Accompanying Warrant
TFF Pharmaceuticals announced the pricing of a public offering of an aggregate of 1,665,219 shares of its common stock (or common stock equivalents in lieu thereof) and warrants to purchase up to 1,66
BenzingaApr 30 16:35
TFF Pharmaceuticals Announces Pricing of $4.8 Million Public Offering
FORT WORTH, Texas, April 29, 2024 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc (NASDAQ:TFFP) (the "Company" or "TFF Pharmaceuticals"), a clinical-stage biopharmaceutical company focused on developing and
GlobeNewswireApr 30 08:00
TFF Pharmaceuticals' 1.7 Million-Share Offering Prices at $2.875 a Share >TFFP
TFF Pharmaceuticals' 1.7 Million-Share Offering Prices at $2.875 a Share >TFFP
Dow JonesApr 30 08:00
TFF Pharmaceuticals Signals Advancements in Investor Update
TipRanksApr 29 18:22
No Data
No Data